Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
View
Robin Foa, EBMT23: Should we transplant all patients with Philadelphia positive ALL?
View
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic
View
Anna Sureda, EBMT23: Improvements in outcomes in autologous stem cell transplantation for patients with Hodgkin lymphoma
View
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice
View
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
View
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View
IMerge Phase 3 study – Imetelstat achieving RBC-TI in lower-risk myelodysplastic syndromes: Rami Komrokji, ASH 2023
View
Johan de Munter, EBMT 2023: Highlights from the Nurses Group Keynote Lecture
View
Phase III APPLY-PNH and APPOINT-PNH trials investigate iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria, 48-week data: Phillip Scheinberg, ASH 2023
View